2012 OSU Molecular Life Sciences
Interdisciplinary Graduate Programs Symposium
Poster abstracts
Abstract:
Malignant gliomas are highly recurrent and virtually impossible to treat with conventional therapies. Glioma invasion, one of the major factors that promotes recurrence, may be regulated in part by interactions between glioma cells and normal neural cells that may facilitate tumor dispersion. Brevican is a brain-specific matrix protein secreted by glioma cells and cleaved by ADAMTS metalloproteases in the matrix around the tumor. This cleavage releases a 50-kDa brevican fragment (
Keywords: Brevican, Glioma, PDGFR